AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

INTERNATIONAL BIOTECHNOLOGY TST PLC

Regulatory Filings May 27, 2025

5163_rns_2025-05-27_71653288-8c7c-4ea1-8782-3084c1a217dc.html

Regulatory Filings

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

RNS Number : 0388K

Intl. Biotechnology Trust PLC

27 May 2025

INTERNATIONAL BIOTECHNOLOGY TRUST PLC ("IBT")

Latest Factsheet and Blog

IBT's factsheet for the month ended 30 April 2025 is now available directly via its web page. Please click here , then 'latest factsheet'.

Successful biotech investing isn't just about spotting winners - it's also about filtering out the likely failures. From dubious clinical data to overconfident founders, Ailsa Craig and Marek Poszepczynski, IBTs Portfolio Managers, have seen it all. In their latest blog post, they take a look at what to expect, with help from the history books.

The blog can be read here: https://www.schroders.com/en-gb/uk/individual/content/spotting-the-red-flags-the-biotech-risks-we-avoid/

To sign up for IBT updates by email, please click here .

ENDS

Enquiries:

Schroder Investment Management Limited

Charlotte Banks (Press)

Kirsty Preston

Kerry Higgins (Company Secretary)
020 7658 6000

020 7658 6000
Kaso Legg Communications (Financial PR)

Charles Gorman            

Henry Taylor

Effie Aye Maung Hider
[email protected]

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

NRAXXLFLEELZBBL

Talk to a Data Expert

Have a question? We'll get back to you promptly.